Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
Scott A. Halperin(Dalhousie University), David Allison, Matthew D. Hall(National Institutes of Health), Shelly Senders(SUNY Upstate Medical University), Stuart Weisman, Tim J. Craig(University of the West of England), Martin L. Kabongo(University of California San Diego), Gary S. Marshall(University of Louisville), Vitali Pool, Catherine Donovan(Memorial University of Newfoundland), Michael D. Decker(Vanderbilt University), Susan Keathley, Joseph K. Leader(Brigham and Women's Hospital), Douglas Mitchell, Kevin Rouse, Laura Helman, D Wyszomierski, Wilson Andrews, Daniel C. Brune(Arizona State University), Leonard B. Weiner(SUNY Upstate Medical University), David L. Bernstein(Drexel University), David R. Johnson(University of Michigan), Mahashweta Mitra Ghosh, Edwin L. Anderson, Gerald Bader, David P. Greenberg(University of Pittsburgh), Ambaram Chauhan, Michael McGuire, Kenneth Bromberg, Randall Middleton, Peter Silas
Cited by 27
Related Papers
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
|PubMed|2003|397
The changing and dynamic epidemiology of meningococcal disease
|Vaccine|2011|304
Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains
|Journal of Biological Chemistry|2001|249
KDM5 histone demethylases repress immune response via suppression of STING
|PLoS Biology|2018|166